CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Laboratory Corporation of America Holdings Company Snapshot
Laboratory Corporation of America Holdings operates within the Medical laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Laboratory Corporation of America Holdings with three other pharmaceutical manufacturers in North America: Biogen Inc (2018 sales of $13.45 billion of which 81% was Product revenues, net), Bausch Health Companies Inc of Canada (10.89 billion Canadian Dollars [US$8.26 billion] of which 56% was Bausch + Lomb / International segment), and Mylan NV ($11.43 billion of which 37% was North America).

Sales Analysis. During the year ended December of 2018, sales at Laboratory Corporation of America Holdings were $11.33 billion. This is an increase of 11.0% versus 2017, when the company's sales were $10.21 billion. This was the fifth consecutive year of sales increases at Laboratory Corporation of America Holdings (and since 2013, sales have increased a total of 95%). Sales of Cdd saw an increase that was more than double the company's growth rate: sales were up 42.0% in 2018, from $3.04 billion to $4.31 billion. Not all segments of Laboratory Corporation of America Holdings experienced an increase in sales in 2018: sales of Lcd fell 1.9% to $7.03 billion.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Laboratory Corporation of America Holdings
  Stock Performance Chart for Laboratory Corporation of America Holdings
 
  Stock Data: Recent Stock Performance:
  Current Price (9/6/2019): 172.93
(Figures in U.S. Dollars)
1 Week 3.2%   13 Weeks 4.8%  
4 Weeks 3.6%   52 Weeks 3.1%  
 
Laboratory Corporation of America Holdings Key Data:
  Ticker: LH Country: United States
  Exchanges: NYSE FRA Major Industry: Health Care Equipment & Services
    Sub Industry: Medical Laboratories
  2018 Sales 11,333,400,000
(Year Ending Jan 2019).
Employees: 61,000
  Currency: U.S. Dollars Market Cap: 16,912,554,000
  Fiscal Yr Ends: December Shares Outstanding: 97,800,000
  Share Type: Common Closely Held Shares: 585,927
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.